Oncoceutics
Latest round
- Series A
Last raised
- Oct 2015
Total raised
- Undisclosed
Investors
- 1
About Oncoceutics
Oncoceutics, Inc.Oncoceutics, Inc. is a biopharmaceutical company based in Philadelphia, US, founded in 2009. The company is dedicated to creating therapeutics that target cancer treatment. The CEO and co-founder, Lee Schalop, has a history in drug development and oncology. In January 2021, Chimerix, Inc. acquired Oncoceutics from Calvert Research LLC and Spring Mountain Capital.Oncoceutics specializes in the development of innovative therapeutics for cancer treatment, focusing primarily on the design and commercialization of small molecular compounds aimed at enhancing the efficacy of existing cancer therapies. Their core product offerings include targeted therapies that disrupt cancer cell proliferation and survival mechanisms, thereby improving patient outcomes in various malignancies.Oncoceutics generates revenue through strategic partnerships and collaborations with healthcare institutions, pharmaceutical companies, and research organizations. Transactions typically involve licensing agreements and co-development partnerships for their proprietary therapeutics. The company aims to expand its market presence in oncology by enhancing its product offerings and penetrating additional geographic regions. As part of its strategy, Oncoceutics is focused on developing upcoming therapies to introduce to the market, further strengthening its position in the oncology landscape.
Who invested in Oncoceutics
1 investor across 1 round
See all investors in Oncoceutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2015
Amount
Undisclosed
Investors
Questions about Oncoceutics
Who invested in Oncoceutics?
Oncoceutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncoceutics raised?
Oncoceutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Oncoceutics last raise money?
Oncoceutics's most recent round on record is a Series A, in Oct 2015.
What does Oncoceutics do?
Oncoceutics is a pharmaceuticals company.
Where is Oncoceutics headquartered?
Oncoceutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Oncoceutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Oncoceutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Oncoceutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.